Serum 25-hydroxyvitamin D concentrations in Mid-adulthood and Parkinson's disease risk

Heart rate variability and the risk of Parkinson disease: The Atherosclerosis Risk in Communities study

(2015) Alvaro Alonso et al.   ANNALS OF NEUROLOGY

The 25-hydroxyvitamin D3 C-3 epimer: Distribution, correlates, and reclassification of 25-hydroxyvitamin D status in the population-based Atherosclerosis Risk in Communities Study (ARIC)

(2015) Pamela L. Lutsey et al.   CLINICA CHIMICA ACTA

Statins, plasma cholesterol, and risk of Parkinson's disease: A prospective study

(2015) Xuemei Huang et al.   MOVEMENT DISORDERS

1,25-Dyhydroxyvitamin D3 attenuates rotenone-induced neurotoxicity in SH-SY5Y cells through induction of autophagy

(2014) Wooyoung Jang et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

Vitamin D from different sources is inversely associated with Parkinson disease

(2014) Liyong Wang et al.   MOVEMENT DISORDERS

Calcitriol Promotes Augmented Dopamine Release in the Lesioned Striatum of 6-Hydroxydopamine Treated Rats

(2014) Wayne A. Cass et al.   NEUROCHEMICAL RESEARCH

The role of vitamin D levels and vitamin D receptor polymorphism on Parkinson's disease in the Faroe Islands

(2014) Maria Skaalum Petersen et al.   NEUROSCIENCE LETTERS

The current and projected economic burden of Parkinson's disease in the United States

(2013) Stacey L. Kowal et al.   MOVEMENT DISORDERS

Unrecognized vitamin D3 deficiency is common in Parkinson disease: Harvard Biomarker Study

(2013) H. Ding et al.   NEUROLOGY

State-of-the-Art Vitamin D Assays: A Comparison of Automated Immunoassays with Liquid Chromatography-Tandem Mass Spectrometry Methods

(2012) C.-J. L. Farrell et al.   CLINICAL CHEMISTRY

High Prevalence of Hypovitaminosis D Status in Patients With Early Parkinson Disease

(2011) Marian L. Evatt   ARCHIVES OF NEUROLOGY

Evaluation, Treatment, and Prevention of Vitamin D Deficiency: an Endocrine Society Clinical Practice Guideline

(2011) Michael F. Holick et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Evoked dopamine overflow is augmented in the striatum of calcitriol treated rats

(2011) Wayne A. Cass et al.   NEUROCHEMISTRY INTERNATIONAL

Prevalence and correlates of vitamin D deficiency in US adults

(2011) Kimberly Y.Z. Forrest et al.   NUTRITION RESEARCH

Serum Vitamin D and the Risk of Parkinson Disease

(2010) Paul Knekt et al.   ARCHIVES OF NEUROLOGY

Vitamin D and multiple sclerosis

(2010) Alberto Ascherio et al.   LANCET NEUROLOGY

Geographic and Ethnic Variation in Parkinson Disease: A Population-Based Study of US Medicare Beneficiaries

(2010) Allison Wright Willis et al.   NEUROEPIDEMIOLOGY

Competing Risk Regression Models for Epidemiologic Data

(2009) B. Lau et al.   AMERICAN JOURNAL OF EPIDEMIOLOGY

Preanalytical Stability of 25(OH)-Vitamin D3 in Human Blood or Serum at Room Temperature: Solid as a Rock

(2009) J. P. M. Wielders et al.   CLINICAL CHEMISTRY

The Effects of Storage Time and Sampling Season on the Stability of Serum 25-Hydroxy Vitamin D and Androstenedione

(2009) Calypse Agborsangaya* et al.   NUTRITION AND CANCER-AN INTERNATIONAL JOURNAL

Prevalence of Vitamin D Insufficiency in Patients With Parkinson Disease and Alzheimer Disease

(2008) Marian L. Evatt et al.   ARCHIVES OF NEUROLOGY

Measurement of 25-hydroxyvitamin D3 (25OHD3) and 25-hydroxyvitamin D2 (25OHD2) in human serum using liquid chromatography-tandem mass spectrometry and its comparison to a radioimmunoassay method

(2008) Huiping Chen et al.   CLINICA CHIMICA ACTA

1,25-Dihydroxyvitamin D3administration to 6-hydroxydopamine-lesioned rats increases glial cell line-derived neurotrophic factor and partially restores tyrosine hydroxylase expression in substantia nigra and striatum

(2008) Begoña Sanchez et al.   JOURNAL OF NEUROSCIENCE RESEARCH

Vitamin D and neurocognitive dysfunction: Preventing “D”ecline?

(2008) Jennifer S. Buell et al.   MOLECULAR ASPECTS OF MEDICINE